A detailed history of Ashton Thomas Private Wealth, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ashton Thomas Private Wealth, LLC holds 41,057 shares of ABT stock, worth $4.67 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
41,057
Previous 39,110 4.98%
Holding current value
$4.67 Million
Previous $4.45 Billion 4.03%
% of portfolio
0.23%
Previous 0.25%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$100.73 - $112.44 $196,121 - $218,920
1,947 Added 4.98%
41,057 $4.27 Billion
Q1 2024

Apr 19, 2024

BUY
$109.52 - $120.96 $426,251 - $470,776
3,892 Added 11.05%
39,110 $4.45 Billion
Q4 2023

Apr 19, 2024

BUY
$90.19 - $110.4 $143,853 - $176,088
1,595 Added 4.74%
35,218 $3.88 Billion
Q3 2023

Apr 19, 2024

BUY
$95.53 - $114.62 $1.34 Million - $1.61 Million
14,055 Added 71.83%
33,623 $3.26 Billion
Q2 2023

Apr 22, 2024

BUY
$100.78 - $112.29 $505,008 - $562,685
5,011 Added 21.8%
27,999 $3.05 Billion
Q1 2023

Apr 22, 2024

SELL
$96.86 - $114.01 $1.56 Million - $1.84 Million
-16,122 Reduced 41.22%
22,988 $2.33 Billion
Q4 2022

Apr 19, 2024

SELL
$95.06 - $111.52 $819,322 - $961,190
-8,619 Reduced 30.58%
19,568 $2.15 Billion
Q3 2022

Apr 19, 2024

BUY
$96.76 - $112.03 $116,402 - $134,772
1,203 Added 4.46%
28,187 $2.73 Billion
Q2 2022

Apr 19, 2024

SELL
$102.07 - $123.37 $483,403 - $584,280
-4,736 Reduced 14.93%
26,984 $2.93 Billion
Q1 2022

Apr 19, 2024

SELL
$114.02 - $139.04 $506,476 - $617,615
-4,442 Reduced 12.28%
31,720 $3.75 Billion
Q4 2021

Apr 19, 2024

BUY
$115.53 - $141.46 $455,765 - $558,059
3,945 Added 12.25%
36,162 $5.09 Billion
Q3 2021

Apr 19, 2024

BUY
$116.66 - $129.06 $167,407 - $185,201
1,435 Added 4.66%
32,217 $3.81 Billion
Q2 2021

Apr 19, 2024

SELL
$105.79 - $124.53 $183,228 - $215,685
-1,732 Reduced 5.33%
30,782 $3.57 Billion
Q1 2021

Apr 19, 2024

SELL
$108.84 - $128.23 $60,732 - $71,552
-558 Reduced 1.69%
32,514 $3.9 Billion
Q4 2020

Apr 19, 2024

BUY
$105.0 - $114.42 $253,680 - $276,438
2,416 Added 7.88%
33,072 $3.62 Billion
Q3 2020

Apr 19, 2024

BUY
$91.64 - $111.29 $202,157 - $245,505
2,206 Added 7.75%
30,656 $3.34 Billion
Q2 2020

Apr 19, 2024

BUY
$76.57 - $98.0 $1.05 Million - $1.35 Million
13,774 Added 93.85%
28,450 $2.6 Billion
Q1 2020

Apr 19, 2024

BUY
$62.82 - $91.86 $465,119 - $680,131
7,404 Added 101.82%
14,676 $1.16 Billion
Q4 2019

Apr 19, 2024

BUY
$78.51 - $87.4 $9,735 - $10,837
124 Added 1.73%
7,272 $632 Million
Q3 2019

Apr 19, 2024

BUY
$81.84 - $88.74 $8,020 - $8,696
98 Added 1.39%
7,148 $598 Million
Q2 2019

Apr 19, 2024

BUY
$72.88 - $85.0 $164,052 - $191,335
2,251 Added 46.91%
7,050 $593 Million
Q1 2019

Apr 19, 2024

BUY
$66.22 - $80.06 $317,789 - $384,207
4,799 New
4,799 $384 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ashton Thomas Private Wealth, LLC Portfolio

Follow Ashton Thomas Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashton Thomas Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashton Thomas Private Wealth, LLC with notifications on news.